Physician profile
William Mclarty
NPI 1114080520
$1,705.21
in general payments reported to CMS, 2019-2025
18 companies · $56.53 in 2025
The $56.53 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $420 · 2020: $217 · 2021: $664 · 2022: $140 · 2023: $80.60 · 2024: $127 · 2025: $56.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $263.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $420.20 | 2020-2025 | Tecvayli, Darzalex, Imbruvica |
| Vanda Pharmaceuticals INC. | $215.67 | 2019-2021 | |
| Abbvie INC. | $215.45 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $189.37 | 2020-2022 | |
| Otsuka America Pharmaceutical, INC. | $184.41 | 2019-2022 | |
| Allergan, INC. | $106.07 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $105.54 | 2019-2021 | |
| Avanir Pharmaceuticals, INC. | $56.99 | 2021 | |
| Ironshore Pharmaceuticals INC. | $34.64 | 2019 | |
| Jazz Pharmaceuticals INC. | $30.74 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $26.39 | 2019 | |
| Lundbeck LLC | $24.20 | 2020-2021 | |
| Bausch Health US, LLC | $24.12 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $18.84 | 2021 | |
| Neuronetics, INC. | $14.04 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $13.86 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.89 | 2019 | |
| Adlon Therapeutics L.P. | $11.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Mclarty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.